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Membrane Lipid TherapyCellular functions are usually associated with the activity of proteins and nucleic acids. Recent studies have
shown that lipids modulate the localization and activity of key membrane-associated signal transduction
proteins, thus regulating the cell's physiology. Membrane Lipid Therapy aims to reverse cell dysfunctions
(i.e., diseases) by modulating the activity of membrane signaling proteins through regulation of the lipid bi-
layer structure. The present work shows the ability of a series of 2-hydroxyfatty acid (2OHFA) derivatives,
varying in the acyl chain length and degree of unsaturation, to regulate the membrane lipid structure.
These molecules have shown greater therapeutic potential than their natural non-hydroxylated counterparts.
We demonstrated that both 2OHFA and natural FAs induced reorganization of lipid domains in model mem-
branes of POPC:SM:PE:Cho, modulating the liquid-ordered/liquid-disordered structures ratio and the
microdomain lipid composition. Fluorescence spectroscopy, confocal microscopy, Fourier transform infrared
spectroscopy and differential detergent solubilization experiments showed a destabilization of the
membranes upon addition of the 2OHFAs and FAs which correlated with the observed disordering effect.
The changes produced by these synthetic fatty acids on the lipid structure may constitute part of their mech-
anism of action, leading to changes in the localization/activity of membrane proteins involved in signaling
cascades, and therefore modulating cell responses.
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The length and degree of unsaturation of natural fatty acids have
been associated with their impact on membrane lipid structure [1] and
human health [2]. In recent years, dietary recommendations have been
made to decrease saturated and trans-fatty acids due to their negative
cardiovascular effects, while mono- and polyunsaturated fatty acids are
recommended for their cardio-protective beneﬁts [3]. During the last
few years, a number of 2OHFAs have been rationally designed for the
treatment of cancer, inﬂammation, Alzheimer's disease, obesity, diabe-
tes, spinal cord injury, etc. Some data available indicate that the mecha-
nism of action of these 2OHFAs is related to their capacity to modulate
themembrane lipid structure [4–6] but themolecular bases of the differ-
ential effects of these fatty acids remain largely unknown. The in vitro
and in vivo studies with these 2OHFAs show that they have greater ther-
apeutic effects than the natural, non-hydroxylated counterparts [7–9]. In
this context, 2-hydroxylinoleic and 2-hydroxyoleic acid are currently
being developed for the treatment of cancer (preclinical and phase I/II
clinical trials, respectively). Moreover, 2-hydroxyoleic acid, a synthetic
monounsaturated fatty acid, is under preclinical development for the
treatment of spinal cord injury, hypertension, diabetes and obesity.
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inﬂammatory effects and 2-hydroxydocosahexaenoic acid has aroused
as an interesting candidate to revert the cognitive deﬁciencies associated
to neurodegenerative processes such as Alzheimer's disease [6,10].
2-Hydroxyoleic acid, which is currently being investigated in
humans for the treatment of glioma, has a potent antitumoral effect
both in vitro [11] and in vivo [12]. Its pharmacological anticancer activ-
ity has been associated with a dual-mode action. On the one hand, this
molecule induces important changes on the lamellar-to-nonlamellar
phase transition that provoke membrane translocation and activation
of PKCα [13]. On the other hand, 2-hydroxyoleic acid induces important
changes in membrane–lipid composition that cause Ras translocation
from the plasma membrane to the cytoplasm followed by autophagic
cell death; however, its molecular mechanism of action is not fully un-
derstood [12,14].
Here, we have studied by means of different biophysical techniques
the effect of various 2OHFAs on the membrane lipid structure. It is
known that alterations in the plasmamembrane structure by lipidmol-
ecules canmodify cell signaling events [15]. Indeed, several compounds
act by regulating signal transduction through a new therapeutic ap-
proach named Membrane Lipid Therapy, which aims to the regulation
of the membrane lipid organization through structure–function princi-
ples [7,16,17]. Changes in the membrane physico-chemical properties,
such as the lateral pressure [18], membrane ﬂuidity [19] or phase be-
havior [16], regulate the localization and activity of relevant signaling
proteins, which results in the regulation of gene expression and rever-
sion of the pathological state within the cell [7].
Anesthetics, such as ketamine, are classical examples of drugs that
alter the cell signaling processes by modulating the lipid membrane
structure [20]. These structural changes in the lipid bilayer may
alter the function of membrane peripheral and integral proteins
such as ion channels, hence blocking neurotransmission and leading
to anesthesia and analgesia [21]. Oleamide, an amide derivative of
the oleic fatty acid, has shown to perturb the ﬂuidity of lipid mem-
branes, thus leading to the regulation of receptors that activate G pro-
teins and thereby playing a role in alertness and sleep [22]. Besides,
membrane lipid structure has also been described to affect enzyme
activity rates, e.g., sphingomyelinases, which hydrolyze SM to give
rise to the apoptosis-related sphingolipid ceramide [23]. It has been
observed that their maximum activity rates increase (i) at high tem-
peratures (>42 °C), that is, when transition temperature of SM
from gel-to-ﬂuid (Tm) has occurred or (ii) when Tm is decreased by
the presence of other lipids such as PC or PE [24].
Lipid rafts are SM and Cho-rich Lo membrane microdomains that
play an important role in cell signaling [25]. Since the discovery of
these lipid structures, extensive research provided evidence that they
are implicated in the pathogenesis of a variety of conditions [26] such
as neurological diseases including Alzheimer's [27], Parkinson's [28]
and prion diseases [29], cardiovascular diseases, immune disorders
such as systemic lupus erythematosus [30] and HIV infection [31].
Lipid rafts have been also implicated in signaling pathways in cancer
progression [32], but how these Lo microdomains affect the adhesion
andmigration of invasive cancer cells remains to be determined hither-
to [33]. The present study shows the ability of different 2OHFAs to in-
duce important changes in the lipid structure and in the composition
and proportion of Lo/Ld (i.e., raft-like-to-non-raft ratio) microdomains.
These regulatory effects can cause relevant modiﬁcations in the locali-
zation of signaling proteins andmay be part of themechanism of action
involved in the therapeutic effects exerted by 2OHFAs.
2. Material and methods
2.1. Materials
POPC, liver bovine PE, chicken egg SM, Cho, and NBD-PE were
from Avanti Polar Lipids (Alabaster, AL). Triton X-100, DMSO, OA,SA, LA, αLNA, γLNA and ARA were purchased from Sigma-Aldrich
(St. Louis, MO). DiI was from Invitrogen (Eugene, OR). Bovine GM1
and 2OHSA were from Larodan (Malmö, Sweden). EPA and DHA
were obtained from BASF Pharma (Callanish, UK). 2OHOA, 2OHLA,
2OHαLNA, 2OHγLNA, 2OHARA, 2OHEPA and 2OHDHA were kindly
provided by Lipopharma Therapeutics S.L. (Palma, Spain). Chloro-
form, methanol, n-hexane, acetic acid and diethylether were bought
to Scharlab (Barcelona, Spain). Silica G60 20 × 20 cm plates were
from Merck (Darmstadt, Germany) and 200 nm Anotop ﬁlters were
purchased from Whatman (Kent, United Kingdom).
2.2. Preparation of lipid vesicles
POPC:PE:SM:Cho (1:1:1:1; mol ratio) LUVs were prepared in a
buffer solution containing 10 mM Hepes, 1 mM EDTA, 100 mM
NaCl, pH 7.4 using an extruder device equipped with 200 nm ﬁlters
as previously described [34]. Quantitative analysis of the lipid compo-
sition of LUV was performed as described elsewhere [35] and data
showed that the ﬁnal composition did not signiﬁcantly differ from
the initial lipid mixture (see Fig. 8F).
2.3. Lipid phase separation studies
Fatty acid-induced phase separation was monitored by the NBD-PE
self-quenching method [36]. Brieﬂy, vesicles containing 5 mol% NBD-
PE show an attenuated ﬂuorescence signal due to ﬂuorescence self-
quenching when the local concentration of the ﬂuorophore increases,
i.e., when this synthetic lipid is segregated out the Lo to Ld domains.
Monitoring of NBD ﬂuorescence was carried out with a Varian Cary
Eclipse Fluorescence Spectrophotometer (Palo Alto, CA). 2 ml of
0.1 mM LUVs were excited at 475 nm and the ﬂuorescence was moni-
tored at 530 nm in quartz cuvettes at room temperature under contin-
uous stirring. The slit widths were 2 nm for both excitation and
emission and the ﬂuorescence signal was normalized to the initial ﬂuo-
rescence value of each kinetic experiment. Fatty acids diluted in DMSO
were added to the liposomemixture at concentrations ranging from 15
to 45 mol%, which are well below the doses of experiments using cell
lines [12,14]. In addition, according to previous observations, 2OHOA
treatment of glioma and lung cancer cells causes the synthetic molecule
to account for ~15% of the fatty acids within the cells [37].
2.4. GUV preparation and ﬂuorescence microscopy
GUVs were prepared using the electroformation method [38].
For this purpose, lipid solutions containing 0.3 mM total lipid
supplemented with 0.4 mol% DiI or 5 mol% NBD-PE were prepared in
chloroform:methanol (2:1, v/v). DiI probe is localized preferentially to
Ld phases [39], as well as NBD-acyl chain labeled PE. Three microliters
of the lipid mixture was added on the surface of platinum electrodes
and solvent traces were removed under high vacuum for 60 min. The
electrodes were covered with 400 μl of 25 mM Hepes buffer, pH 7.4,
previously heated at 50 °C. The platinum wires were connected to an
electric wave generator at 50 °C under the following AC ﬁeld condi-
tions: 500 Hz, 0.22 V for 5 min; 500 Hz, 1.9 V for 20 min and ﬁnally
500 Hz, 5.3 V for 90 min. After GUV formation, the cuvette containing
the electrodes was placed on a Leica TCS SPE inverted confocal ﬂuores-
cence microscope (Barcelona, Spain). The excitation wavelengths used
were 488 nm and 532 nm for NBD-PE and DiI, respectively. When re-
quired, fatty acids dissolved in DMSO were added to a ﬁnal concentra-
tion of 0.135 mM and changes in the morphology and ﬂuorescence of
vesicles attached to the platinum wire were monitored.
2.5. FTIR spectroscopy
Fifty microliters of lipid samples in 5 mM Hepes buffer, pH 7.4
containing 0.5 mM EDTA, and 50 mM NaCl was dehydrated in a speed
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interference of H2O infrared absorbance (1645 cm−1). Sampleswere hy-
drated overnight at a temperature of 32 °C before starting the acquisition
of the FTIR spectra. Sample measurements were performed in a liquid
demountable cell (Harrick, Ossining, NY, USA) equipped with CaF2 win-
dows and 25-mm-thick Mylar spacers. FTIR spectra were acquired on a
spectrometer IF66/s (Bruker Optics Inc.), equipped with deuterated
triglycine sulfate (DTGS) detectors. The sample chamber was constantly
purgedwith dry air. Aminimumof 100 scans per spectrawere taken, av-
eraged, apodized with a Happ–Genzel function and Fourier-transformed
to give a nominal resolution of 2 cm−1. Self-deconvolution was
performed using a Lorentzian bandwidth of 18 cm−1 and a resolution
enhancement factor of 2.0. Samples were scanned in the temperature
range of 20–70 °C, every 2 °C. The duration of a complete heating cycle
was of approximately 3 h. Afterwards, samples were cooled and equili-
brated at 20 °C to check the reversibility of the transitions. Buffer contri-
butions were subtracted from the individual spectra, and the resulting
spectra were used for analysis [40].2.6. Sigmoidal data ﬁtting analysis
Certain infrared and dichroism data presenting a sigmoid behav-
ior cannot be satisfactorily explained with the typical Boltzmann
equation, especially if they have big negative or positive sloping
bottom and top plateau. From the Boltzmann equation we have de-
veloped a new equation that takes into account the positive or neg-
ative plateau.
Boltzmann ¼> y ¼ A2þ A1−A2ð Þ= 1þ exp x−x0ð Þ=dxð Þð Þ
Boltzmann modified ¼> y ¼ A2þ B2  xþ A1þ B1  x−A2−B2  xð Þ
= 1þ exp x−x 0ð Þð Þ=dxð Þð Þ
where A1 is the initial value (left horizontal asymptote), B1 is the
slope for the initial asymptote, A2 is the ﬁnal value (right horizontal
asymptote), B2 is the slope for the ﬁnal asymptote, x0 is the center
(point of inﬂection), and dx is the width (the change in X corre-
sponding to the most signiﬁcant change in Y values). Curve ﬁtting
analysis using “Boltzmann modiﬁed” equation was performed with
OriginLab 7.0.Fig. 1. Effects of 2OHFAs on NBD-PE ﬂuorescence intensity in LUVs. (A) Large
unilamellar vesicles composed of POPC:SM:PE:Cho (1:1:1:1 mol ratio) + 5% NBD-PE
were incubated with 15, 30 and 45 mol% of 2OHOA in DMSO. Bar diagrams show the
ﬂuorescence intensity changes after addition of 15 mol% of (B) 2-hydroxylated and
(C) non-hydroxylated fatty acid molecules. Bars show mean ﬂuorescence values of
3 measurements ± SD. *p b 0.05, **p b 0.01 and ***p b 0.001. # means p b 0.05 or
greater signiﬁcance compared to the control experiment (DMSO). § means p b 0.05
or greater signiﬁcance compared to (B) OA or LA and (C) 2OHOA. λex = 475 nm and
λem = 530 nm.2.7. Determination of lipid composition in Lo and Ld membrane domains
One milliliter of LUVs (containing 2.5 mM of lipid) composed of
POPC:PE:SM:Cho (1:1:1:1; mol ratio) + 1 mol% GM1 was incubated
in the absence or presence of 15 mol% of various FAs and 2OHFAs at
room temperature for 30 min under continuous stirring. Concentra-
tions below 2 mol% GM1 do not modify the lipid membrane struc-
ture [41], so it was added to the lipid mixture as a marker for DRM
fractions [42]. Vesicles were incubated at 4 °C for 1 h in the presence
of 1% Triton X-100 (w/v) and the DRM fraction was separated from
detergent-lipid mixed micelles by ultracentrifugation (80,000 g, 5 h)
at 4 °C. The pellet (DRM) was suspended in 500 μl of water, both pellet
and supernatant were lyophilized overnight and lipids were separated
on thin-layer chromatography plates [43]. Brieﬂy, two consecutive de-
velopments with chloroform:methanol:water (60:30:5; v:v:v) were
done: the solvent front was left to reach the upper part of the plate
for the ﬁrst run following a second development until the solvent cov-
ered half of the plate. A third separation was performed in n-hexane:
diethylether:acetic acid (80:20:1.5; v:v:v). Plates were charred with a
5% CuSO4/4% H3PO4 solution and spots were developed at 180 °C for
15 min. Lipid quantiﬁcation was accomplished by image analysis in a
GS-800 densitometer using the Quantity One software from Bio-Rad
Laboratories (Hercules, CA).3. Results
3.1. Unsaturated 2OHFAs induce Lo/Ld microdomain reorganization
Time course ﬂuorescence kinetics were recorded in LUVs composed
of POPC:PE:SM:Cho (1:1:1:1; mol ratio) containing 5 mol% NBD-PE
upon addition of 15, 30 and 45 mol% of 2OHOA (Fig. 1A). At room tem-
perature, these quaternary lipid mixture membranes display lateral
lipid heterogeneity, i.e., distinct lipid domains are formed [44]: one Lo,
lipid raft-like, phase enriched in SM and Cho, and another domain
enriched in the Ld-forming lipids PE and POPC. The acyl chain-labeled
NBD-PE has a preference for the more ﬂuid and disordered phases as
shown in Fig. S1 and colocalizes with the also Ld-preferring DiI probe
[39]. The addition of 2OHOA to the lipid vesicles induced signiﬁcant
increases of the ﬂuorescence intensity in a concentration-dependent
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cence (Fig. 1A). Addition of 15 mol% of any of the hydroxylated fatty
acid derivatives, with the exception of the saturated fatty acid 2OHSA,
induced a high increase in ﬂuorescence signal (Fig. 1B); subsequent ad-
ditions of the unsaturated, 2OHFAs, although to a lesser extent, pro-
duced further increases of the ﬂuorescence signal (data not shown).
All non-hydroxylated fatty acid derivatives but SA, also induced an in-
crease in the ﬂuorescence intensity (Fig. 1C) caused by the disordering
effect within the membrane upon insertion of the FA molecules.
NBD-PE ﬂuorescence was reduced caused by self-quenching due to a
heterogeneous distribution of the ﬂuorophore accumulation in Ld do-
mains; however, after insertion of 2OHFA and FA in the lipid bilayer
the ﬂuorescence was increased due to the more homogeneous lipid
reorganization.
The highest disordering effect was caused by OA and 2OHOA
among the natural and 2-hydroxylated fatty acid derivatives, respec-
tively. Thus, the presence of an 18-carbon acyl chain in combination
with a single cis double bond possessed the most potent reorganizing
effect on the used model membranes. Further increase in the number
of carbon atoms or in the number of double bonds induced signiﬁcant
homogeneous redistribution of lipid components in the membrane
although to a lesser extent compared with OA and 2OHOA.
3.2. 2OHFAs induced structural changes of model membranes observed
by confocal ﬂuorescence microscopy
The time sequence of the effects of 2OHFA derivatives on POPC:PE:
SM:Cho (1:1:1:1; mol ratio) vesicles is shown in Fig. 2. DiI partitions
preferentially into the more disordered Ld domains enriched in PE
and POPC, thus at time 0 min, yellow (Ld) and dark (Lo, lipidFig. 2. Effects of 2OHFAs on membrane domain organization by confocal microscopy.
GUVs composed of POPC:SM:PE:Cho (1:1:1:1; mol ratio) were incubated with
0.135 mM 2OHSA, 2OHOA, 2OHARA and 2OHDHA. Ld domains were stained with DiI
(yellow) while Lo structures appear as dark domains. Representative images were
taken at different times after addition of the fatty acid. DMSO was used as a negative
control. Bar = 10 μm.raft-like) domains coexist under the experimental conditions used,
which agrees with previous studies [39]. However, after addition of
the 2OHFAs, the proportion of Ld domain increased with time, until
apparent disappearance of Lo domains. Fig. 3 shows the relative
lengths of the Ld and Lo domains at the confocal equatorial plane as
a relative measurement of the Ld and Lo size through the incubation
time. Before the addition of 2OHSA, 2OHOA, 2OHARA and 2OHDHA,
vesicles showed a heterogeneous distribution of lipids in which
~50% of the perimeter was occupied by Lo and the other half by Ld
structures. Upon addition of the 2OHFA derivatives, quantiﬁcation of
Lo and Ld domains showed a continuous reduction of Lo structures
that correlated with the increase of Ld (DiI-containing) domains. In-
terestingly, digital analysis of the overall ﬂuorescence in vesicles
showed a slight tendency to increase, although without signiﬁcant
differences, after incubation of the 2OHFAs (Table 1). Fig. S1 showsFig. 3. Quantiﬁcation of lipid domains in GUV after incubation with 2OHFAs. Percent-
age of Lo and Ld lipid domains was quantitated from confocal ﬂuorescence images of
GUVs at different times after addition of 2OHSA, 2OHOA, 2OHARA and 2OHDHA.
Data show average values of Lo and Ld domains from 8 to 10 vesicles ± SD.
Table 1
Change of overall ﬂuorescence intensity in GUVs upon incubation with 2OHFA.
F0 sa F180 s
2OHOA 16.0 ± 3.3 16.5 ± 3.7
2OHARA 21.6 ± 2.6 21.8 ± 3.3
2OHDHA 10.2 ± 0.9 12.5 ± 1.3
a F means mean ﬂuorescence intensity (arbitrary units) at time 0 s and 180 s after
addition of 2OHFA derivatives.
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of POPC:PE:SM:Cho (1:1:1:1; mol ratio). Both ﬂuorescent probes lo-
calized in the more disordered domains, demonstrating a similar
phase partition behavior and a correlation between the results ob-
served by ﬂuorescence spectroscopy (Fig. 1) and confocal microscopy
(Figs. 2 and 3). The NBD-PE molecule with the ﬂuorescence probe
linked to the hydrophilic headgroup has been elegantly designed as
a marker for lipid-rafts [45]; however, it has also been proven that
the NBD ﬂuorophore attached to the acyl chain of PE, as the one
used in the present work, imposes steric and polarity constrains in
the hydrophobic region of lipid bilayer [46]. The result is the almost
perfect exclusion of acyl chain-labeled phospholipids from ordered
lipid phases and their preferential accumulation into the disordered
domains.
Concerning the changes induced in the vesicles structure, the ex-
ternal addition of 2OHFAs in a GUV suspension caused the following
effects: (i) in vesicles with coexisting Lo and Ld domains, the Lo
phase area decreased or eventually faded away, giving rise to an ap-
parently homogeneous single Ld structure; (ii) vesicles in contact
with 2OHOA lost the spherical shape and became oval. Regarding
the naturally occurring, non-hydroxylated FAs, the effect is similar
to that of the hydroxylated counterparts (Fig. 4), that is, amount ofFig. 4. Effects of FAs on membrane domain organization by confocal microscopy. GUVs
composed of POPC:SM:PE:Cho (1:1:1:1; mol ratio) were incubated with SA, OA, ARA
and DHA. Ld domains are stained with DiI (yellow) while Lo phases appear as dark do-
mains. Representative images were taken before and after 180 s of addition of FAs.
DMSO was used as a negative control. Bar = 10 μm.the DiI-stained (Ld) region increased at the same time that the pro-
portion of dark, lipid raft-like (Lo) domain decreased and apparently
disappeared.
3.3. Effects of FA and 2OHFA derivatives on membrane lipid structure by
Fourier transform infrared spectroscopy
The effect of unsaturated FAs and their 2-hydroxy derivatives on
the lipid membrane was studied by monitoring the temperature-
dependent responses in several characteristic bands in the infrared
spectra of the samples. The phospholipid carbonyl stretching band,
probing the interfacial region of the lipid membrane, shows two
component bands at 1745 and 1722 cm−1, respectively, upon self-
deconvolution of the original spectra. These two bands are assigned
to dehydrated (1745 cm−1) and hydrated (1722 cm−1) carbonyl
groups [47]. As shown in Fig. 5 (panels A–C) and Fig. 7A, the intensity
of the hydrogen-bonded component (lower frequency) in the POPC:
PE:SM:Cho quaternary mixture was greater than that from the
dehydrated one. The 1745 cm−1/1722 cm−1 ratio decreased as the
temperature increased up to 55 °C, where it acquired a sigmoid-like
behavior with an initial increase and a subsequent decrease in the sig-
nal ratio, characteristic of a new phase transition. The best ﬁt of the
data to a modiﬁed Boltzmann equation (see Material and methods)
allowed us to calculate a phase transition temperature of 62.3 °C. In-
dividual components in our quaternary matrix, such as egg-SM and
liver-PE, experience transitions from lamellar-to-nonlamellar phases.
For instance, egg yolk-PE alone presents a transition from the
liquid-crystalline (Lα) to the inverted hexagonal (HII) phase at 28 °C
[48]. Bovine brain SM can give raise to a nonlamellar phase transition
at high temperature and the inclusion of 20 mol% egg-PC strongly in-
creases it up to 63 °C [49]. More recent studies have shown two tran-
sition for 18:1-SM:Cho mixtures at 35–37 °C and 95 °C, but none
were related to non-lamellar phases, as 31P-NMR spectra for these
range of temperatures are typical of lamellar phases [50]. Thus, we
cannot assigned the transition observed at 62.3 °C in the carbonyl sig-
nal ratio from our quaternary mixture to a lamellar to nonlamellar
phase transition of the SM component, though undoubtedly SM is in-
volved in the transition. Such involvement was unambiguously con-
ﬁrmed by monitoring of the amide I band region of the spectra
(Fig. 6), in which the only contribution from the components of our
quaternary mixtures arises from the amide bond in SM [51] and
shows an abrupt increase in band frequency with a midpoint temper-
ature of 68 °C.
The addition to the lipid vesicles of either FA or 2OHFA derivatives
had similar effects on the phospholipid carbonyl band, regardless of
the hydrocarbon chain length or the number of double bonds. In all
cases, hydration of the carbonyl groups increased, both before and
after the phase transition and the transition temperatures decreased
(see Fig. 5 A–C). A similar conclusion on the effects of FA and
2OHFA derivatives in decreasing the transition temperatures was de-
rived from the monitoring of the SM-speciﬁc, amide I spectral band
(Figs. 6 and 7C).
The region 3000–2800 cm−1 of the infrared spectra (Fig. 7B) in-
cludes several bands resulting from lipids acyl chains, mainly terminal
methyl groups (asymmetric stretch at 2956 cm−1 and symmetric
stretch at 2875 cm−1) and all the methylene groups (antisymmetric
stretch at 2920 cm−1 and symmetric stretch at 2850 cm−1). The abso-
lute frequency of this band is sensitive to the conformational order of
the acyl chain and to the trans-gauche isomerization of the lipids [52].
In addition, the increase in width of these bands is characteristic of
phospholipid hydrocarbon chain-melting phase transitions and arises
from the increase in hydrocarbon chain mobility and conformational
disorder that occur when all-trans polymethylene chains melt [52].
The analysis of the symmetric methylene band (2850 cm−1) for our
samples reveals a similar behavior to that evidenced from the carbonyl
and the amide I bands. Any of the three non-hydroxylated or the
Fig. 5. FTIR temperature proﬁles of POPC:SM:PE:Cho (1:1:1:1; mol ratio) in the presence or absence of 15 mol% FA or 2OHFA. Temperature-dependent changes (A–C) in the inten-
sity band ratio of the carbonyl stretching modes and in (D–F) the maximum frequency of the CH2 symmetric stretching. FTIR spectra are shown for (A, D) 2OHOA and OA, (B, E)
2OHARA and ARA and (C, F) 2OHDHA and DHA added to matrices of POPC:PE:SM:Cho bilayers. Quaternary POPC:PE:SM:Cho (control,■) mixture in the presence of 15 mol% FA ( )
or 15 mol% 2OHFA (Δ) are shown in each panel. Melting temperatures for each curve are indicated with arrows. The solid line represents the best ﬁts of experimental data to a
modiﬁed sigmoid equation (see Material and methods).
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temperature and increased the methylene frequency between 0.5 and
1.5 cm−1, depending on each fatty acid (see Fig. 5 D–F). A change in fre-
quency was also accompanied by an increase in the width of the CH2
symmetric stretching band in the presence of both FA and 2OHFA
(data not shown).
3.4. Effects of FAs and 2OHFAs on the Lo/Ld domain ratio
Model membranes (LUVs) with or without 15 mol% of 2OHFAs or
FAs were treated with the anionic detergent Triton X-100 at 4 °C with
constant stirring, following centrifugation to separate the DRM (pel-
let) from the solubilized fraction (supernatant). Vesicles made from
the quaternary lipid mixture and treated with vehicle (DMSO) and
1% Triton X-100 (w/v) were used as control. The proportion of lipidraft-like, Lo structures (DRM fraction), decreased in the presence of
2-hydroxylated (Fig. 8A) and non-hydroxylated (Fig. 8B) fatty acids
compared to the control vesicles. Both FAs and 2OHFAs signiﬁcantly
reduced the amount of Lo domains from ca. 50% to ca. 38–42% of
the total lipid amount in the vesicles. The ca. 10% reduction in the
DRM fraction might not reﬂect the dramatic decrease (ca. 100%)
seen in confocal microscopy studies (Figs. 2, 3), although the differ-
ence was statistically signiﬁcant for all FAs or 2OHFAs used. As
shown in Fig. 8C and D, DRM fractions in control vesicles were com-
posed basically by the Lo forming lipids SM and Cho, although small
amounts of the PE and POPC were also found. When vesicles were
treated with the 2OHFAs (Fig. 8C) or FAs (Fig. 8 D), the lipid compo-
sition of the DRM fractions changed when compared to the control
vesicles. Thus, the proportion of the order-inducing lipids Cho and
SM increased while the amount of POPC and PE decreased in
Fig. 6. Temperature dependence of “sphingomyelin amide I” infrared band. The fre-
quency of the maximum “sphingomyelin amide I” band is plotted versus temperature
for matrices of POPC:PE:SM:Cho lipid bilayers alone (■) and with FA ( ) and 2OHFA
(Δ): (A) 2OHOA and OA, (B) 2OHARA and ARA and (C) 2OHDHA and DHA. Melting
temperatures for each curve are indicated with arrows in all panels. The solid line rep-
resents the best ﬁts of experimental data to a modiﬁed sigmoid equation (see Material
and methods).
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ﬂuorescence lifetime measurements [14]. Interestingly, neither
2OHFAs nor FAs were found in the DRM fractions (data not shown).
Lipid quantiﬁcation data from vesicles not solubilized with Triton
X-100 were used as non-solubilization controls and they clearly
showed that virtually all the lipid amount was recovered in the pellet
fraction independently of the presence of DMSO (Fig. 8E). Moreover,
the proportion of each lipid from the pellet fraction remained con-
stant in both control samples (Fig. 8F). Altogether the herein
presented results suggest that the size of raft-like domains was dras-
tically reduced, so that they could not be seen by confocal microsco-
py, but they are not eliminated, as about 80% of DRMs are recovered
upon FA/2OHFA addition in detergent solubilization studies.4. Discussion
Membrane Lipid Therapy is a novel therapeutic approach aiming to
the regulation of the composition and structure of cell membranes in
order to modulate the localization and activity of membrane signaling
proteins and subsequently, downstream molecular events [7]. In line
with this, the Mediterranean diet is associated with a blood pressure
reduction and lower incidence of hypertension, which has been di-
rectly associated with OA intake [53]. In addition, omega-3 polyunsat-
urated fatty acids such as DHA and EPA have been associated with
prevention of cardiovascular diseases and cancer [54], while the
omega-6 polyunsaturated fatty acid γLNA is known to possess anti-
inﬂammatory properties [55]. In this scenario, several 2OHFAs have
been designed and they have shown a great efﬁcacy for the treatment
of cancer (2OHOA), Alzheimer's disease (2OHDHA) and inﬂammation
(2OHARA) [6,12]. All these effects share common molecular bases, in
which the regulation of the membrane lipid structure is a key molec-
ular event that controls protein–lipid and protein–protein interac-
tions at deﬁned domains in order to restore physiological processes
in pathological cells.
The aim of the present manuscript was to determine the effect of
natural and 2-hydroxylated FAs immediately after insertion in the
lipid membrane and before becoming part of phospholipid acyl
chains [43]. Some previous works have extensively shown the efﬁca-
cy of OA [56] and 2OHOA [4] in decreasing the lamellar-to-hexagonal
transition temperature in lipid membranes. Here, we have demon-
strated that the addition of several unsaturated 2OHFAs (besides
2OHOA) or FAs (besides OA) to POPC:PE:SM:Cho (1:1:1:1; mol
ratio) membranes, a lipid mixture used as a model to mimic the cell
membrane structure, induced re-organization of lipid domains and
changes in the lipid composition of membrane regions as compared
with control samples. Figs. 1–6, show through different experimental
approaches, an important re-organization of the membrane structure
in the presence of the unsaturated fatty acid derivatives. This fatty
acid-induced effect could be due to their tendency to favor negative
membrane curvature strain [1,56]. This ability to modify the mem-
brane biophysical properties explains in part how FAs and 2OHFAs
modulate the localization and activity of peripheral and integral
membrane proteins and subsequent intracellular cell signaling pro-
cesses. For instance, polyunsaturated fatty acids have been shown to
modulate antigen presentation by changing the organization of lipids
and proteins in the plasma membrane [57]. Other drugs, such as the
anesthetic ketamine [20] and the anti-tumor drugs cisplatin and
doxorubicin [16,58], also exert their activities through the modula-
tion of the membrane structure.
Lipid phase separation studies using the NBD-PE self-quenching
method (Fig. 1) and FTIR data (Figs. 5–7) showed a destabilization
of the membrane structure upon addition of the 2OHFAs derivatives.
The decrease of the carbonyl group signal values (1745/1722 ratio)
indicated a higher hydration level of samples containing 2OHFAs
and FAs molecules (Fig. 5) and the symmetric methylene band signal
appeared at higher wavenumber values in the presence of 2OHFAs or
FAs compared to control samples (Fig. 6), indicating an increase of the
hydrocarbon chain mobility. Moreover, the presence of 2OHFAs in-
duced a homogeneous distribution of DiI ﬂuorescence that could be
related to a loss of Lo domains as seen in ﬂuorescence confocal mi-
croscopy images (Fig. 2) and the size measurements of the Lo and
Ld regions (Fig. 3). However, Triton X-100 solubilization assays
clearly showed that the amount of Lo structure only decreased from
~50% to ~40% in lipid membranes containing FAs or 2OHFAs
(Fig. 8). Although the decrease of the DRM fraction upon incubation
with 2OHFAs or FAs (Fig. 8 A, B) was not as marked as suggested by
ﬂuorescence and confocal microscopy experiments (Figs. 1–3), the
reduction of total lipids in Lo microdomains was statistically signiﬁ-
cant. In addition, the digital analysis of GUV images before and after
incubation with 2OHFA derivatives showed no signiﬁcant differences
Fig. 7. Lipid infrared spectra. (A) Infrared spectra for POPC:PE:SM:Cho (1:1:1:1;mol ratio)
in the absence (black line) or presence of 15 mol% OA (blue line) or 15 mol% 2OHOA (red
line), in the carbonyl (1770–1680 cm−1) region at 23 °C. (B) Temperature-dependent be-
havior of the methylene symmetric stretching (2865–2830 cm−1) and methyl antisym-
metric (2947–2878 cm−1) infrared spectrum of POPC:PE:SM:Cho (1:1:1:1; mol ratio)
with 2OHOA; there are 27 individual spectra, each about 2 °C apart. (C) Infrared spectra
of carbonyl and “sphingomyelin amide I” bands for POPC:PE:SM:Cho (1:1:1:1; mol
ratio) with 2OHOA at 23 °C (dashed line) and 73 °C (continuous line). Each spectrum of
panel C showed the maximum frequency of the “sphingomyelin amide I” band. In all
cases samples were suspended in 10 mM Hepes, pH 7.4, containing 1 mM EDTA, and
100 mM NaCl. CaFB2B windows were used in the spectrometer cell.
Fig. 8. Effect of 2OHFAs on DRM (i.e., Lo domains) proportion in model membranes. Ves-
icles composed of POPC:SM:PE:Cho (1:1:1:1; mol ratio) containing 1 mol% GM1were in-
cubated in the presence or absence of 15 mol% 2OHOA, 2OHARA and 2OHDHA and
solubilizedwith TX100 at 4 °C for 60 min. (A, B)The lipid composition from the detergent
resistant fractions (DRM) was quantiﬁed by thin layer chromatography and compared
with control vesicles in the presence of 2OHFAs and non-hydroxylated FAs. (C, D) The dif-
ferent lipid species contained in the DRM fraction were quantiﬁed and compared to con-
trol vesicles (solid bars) after treatment with 2OHOA (gray bars), 2OHARA (open bars)
and 2OHDHA (striped bars) in panel C and with OA (gray bars), ARA (open bars) and
DHA (striped bars) in panel D. (E) Vesicles treated in the absence of Triton X-100 and
DMSO (C−/−) or in the absence of Triton X-100 but in the presence of DMSO (C−/+).
The vesicles were processed as indicated in Material and methods and the amount of
total lipids in the pellet fraction after centrifugation was quantiﬁed densitometrically.
(F) Densitometric quantiﬁcation of each lipid species in the pellet fraction of C−/−
(gray bars) and C−/+ (white bars) vesicles. Bars represent means of at least 3 indepen-
dent experiments ± SEM. * means p b 0.05, ** p b 0.01 and *** p b 0.001, compared to
control vesicles.
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that the Lo were still present in the lipid bilayer.
Fig. 9 shows the proposed model that explains the above men-
tioned, apparently contradictory results by which the presence of FA
and 2OHFA derivatives induces membrane domain reorganization.
This model also explains in part the frequent presence of small
microdomains in cell membranes, whereas large microdomains like
those involved in protein capping (or extensive clustering), are not
so frequent. 2OHFAs and FAs most likely caused lipid redistribution
and a decrease in the proportion of Lo domains with respect to Ldstructures. The fact that no DiI-depleted regions were visualized in
GUVs containing 2OHFAs or FAs (Fig. 2-4) in combination with deter-
gent solubilization studies (Fig. 8), suggest that the size of Lo domains
drastically decreased below the resolution limit of optical microscopy
(ca. 200 nm). FTIR data (Fig. 5 and 6) showed a strong destabilization
of the lamellar phase of Lo domain (Tm decrease between 4-12 °C,
depending on each fatty acid), which is consistent with the size re-
duction of Lo domains. On the other hand, the remaining Lo struc-
tures became enriched in Cho and, to a lesser extent, in SM as
compared to control vesicles which indicates that 2OHFAs and FAs in-
duced changes in Ld-prone (PE, PC) and Lo-prone (SM, Cho) lipid
intermixing between membrane domains. These results suggest a ri-
gidifying effect in the lipid raft-like, Lo domains and an increased dis-
order in Ld regions, which correlates with previous results [37]. In
that study, 2OHOA was observed (i) to increase the trans-parinaric
acid long lifetime component, indicating that the ordered domains
became more ordered and (ii) to decrease the anisotropy value of
1,6-diphenyl-1,3,5-hexatriene, probing a decrease in the global
order of the membrane. This new membrane organization seen in
the presence of 2OHOA may modify certain membrane protein activ-
ities or protein–protein interactions involved in the propagation of
cell signals related to cancer cell differentiation and survival [12].
Fig. 9. Model for the lipid domain reorganization induced by 2OHFAs on membranes.
Lo/Ld domain ratio is reduced from ca. 50 to ca. 40% of the total membrane surface
upon insertion of 15 mol% 2OHFA derivatives in a lipid membrane. The size of Lo do-
main decreases so that they may not be observed under a ﬂuorescence confocal micro-
scope; however, the presence of Lo domains is supported by the measure of a relevant
DRM fraction after detergent solubilization.
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rated FAs, whereas it decreases with saturated FAs, which possess rigid
hydrocarbon tails [59]. Moreover, the plasmamembrane is a cell struc-
ture where both permanently and non-permanently associated pro-
teins exert their functions, which at the same time are affected by the
surrounding lipid environment [60]. For instance, c-Src, amembrane as-
sociated tyrosine kinase, is a molecule responsible for the activation of
Jun Kinases (JNK) by saturated fatty acids [61]. Saturated fatty acids in-
duce the localization of c-Src into membrane sub-domains of reduced
ﬂuidity and increased rigidity, where it accumulates in an activated
form that eventually leads to ligand-free activation of JNK, a family of
proteins implicated in the development of type 2 diabetes, insulin resis-
tance, obesity and atherosclerosis. By contrast, unsaturated fatty acids
prevent c-Src clustering (in agreement with the above model, Fig. 9),
thus inhibiting JNK activation [61]. Saturated FAs also cause PKC-
dependent activation of mixed-lineage protein kinases (MLK3) that
subsequently causes increased JNK activity by a mechanism that
requires the MAP kinase kinases MKK4 and MKK7 [62]. Moreover,
PKCα and G-protein interactions with membranes and related
signaling events are highly dependent on the membrane structure
and microdomain distribution, and 2OHFAs and FAs can inﬂuence all
these events [5,8,13,16].
Another example of lipid-modulated proteins are heat shock pro-
teins (HSP), which are involved in diverse cell dysfunctions that lead
to the development of insulin-resistant diabetes, cancer and the neu-
rodegenerative disease amyotrophic lateral sclerosis. It is known that
the physical state of the membrane can modulate the expression of
genes encoding for HSPs, thus, leading to different cell responses
[63]. For instance, mild changes in temperature could result in a fun-
damentally altered ﬂuidity of the membrane and, consequently, in
the distribution and activity of stress-sensing and stress-signaling
proteins within the lipid domains [64].
It has been described a more potent therapeutic effect for the hy-
droxylated molecules compared to non-hydroxylated FAs [7–9]. For
instance, the introduction of a hydroxyl group in the α-position of
oleic acid potentiated the efﬁcacy in the reduction of body weight
or blood pressure more than four-fold compared to the non-
hydroxylated OA molecule [9,53]. However, the present data show
that both natural and 2-hydroxy fatty acid derivatives exert similar
physical changes in lipid membranes, so the hydroxyl group might
not be directly responsible for the observed therapeutic effects. An
explanation for the increased therapeutic response of these synthetic
2OHFA derivatives is the fact that α-hydroxy-substituted fatty acids
cannot be directly metabolized via the β-oxidation pathway, but
must ﬁrst enter the α-oxidation pathway where the 2-hydroxy-
phytanoyl-CoA lyase is the rate-limiting enzyme [65]. This enzyme
may become rapidly saturated with low substrate concentrations,
as it represents a secondary oxidation pathway for non-abundant
natural fatty acids and, as a consequence, 2OHFAs may accumulateto a much higher extent than naturally occurring FAs, which are pre-
dominantly used as a source of energy [9]. In addition, the extra hy-
droxyl group may help these FAs establish further hydrogen bonds
that may stabilize their presence in the membranes [4]. Other mech-
anisms involving their incorporation into membrane phospholipids
or interaction with membrane proteins should not be discarded. In
any case, the results have shown the inﬂuence of free FAs and
2OHFA in the lipid membrane structure and organization and also
provided relevant information about the differential effect of each
lipid species that explain in part the sometimes divergent and often
common effect on membrane lipid structure and human health.
Thus, saturated FAs/2OHFAs have not shown to modulate the mem-
brane biophysical properties or improve human health, whereas
their unsaturated analogs have opposite effects on both lipid struc-
ture and therapeutic effects.
5. Concluding remarks
The combination of the slowmetabolization rate and the capacity to
modify lipid organization in membranes, make 2OHFA derivatives po-
tential molecules to revert cell dysfunctions. In this scenario, the modu-
lation of the cell lipid bilayer structuremay be part of themechanism of
action of the 2OHFAs. That is, 2-hydroxyoleic acid and related com-
pounds may act as regulators of cell signaling cascades which are initi-
ated in the membrane and that may lead to cell responses such as cell
differentiation, cell cycle arrest, apoptosis or autophagy through what
has been named as Membrane Lipid Therapy.
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